Investor Relations

Stock price graph

GenMark Dx's mission is to become the market leader in providing high value, simple to perform, clinically relevant multiplex molecular tests to aid in the diagnosis of disease and the selection and dosing of therapies.

For investor information, please contact IR@genmarkdx.com.

Annual Reports

2014 Annual Report

2014 Proxy Statement

2013 Annual Report

2013 Proxy Statement

2012 Annual Report

2011 Annual Report

2012 Proxy Statement


Recent Releases

May 27, 2015
GenMark Diagnostics to Present at the William Blair 35th Annual Growth Stock Conference

May 5, 2015
GenMark Diagnostics Reports Q1 Financial Results

View all releases »

Events

Jun 10, 2015 at 3:20 PM CT
William Blair 35th Annual Growth Stock Conference

View all events »

Related Links

Stock Quote
Price:
8.68
Change:
- 0.38
Day High:
9.17
Day Low:
8.66
Volume:
193,400
NASDAQ
GNMK
3:35 PM ET on Jul 1, 2015
Delayed at least 20 minutes.
Provided by eSignal.